Protein detail

CD4

T-cell surface glycoprotein CD4 (T-cell surface antigen T4/Leu-3) (CD antigen CD4)

Protein symbol
CD4
UniProt ID
EVMP score
0.50
Frequency
5
Transmembrane count
1
Protein classification
CD markersDisease related genesFDA approved drug targetsHuman disease related genesPredicted intracellular proteinsPredicted membrane proteinsTransporters
Basic Information
Protein Names
T-cell surface glycoprotein CD4 (T-cell surface antigen T4/Leu-3) (CD antigen CD4)
Protein Class
CD markersDisease related genesFDA approved drug targetsHuman disease related genesPredicted intracellular proteinsPredicted membrane proteinsTransporters
Protein Function
  • Predicted intracellular proteins
  • CD markers
  • Human disease related genes:Immune system diseases:Primary immunodeficiency
  • Transporters:Accessory Factors Involved in Transport
  • Disease related genes
  • FDA approved drug targets:Biotech drugs
Transmembrane
397..418; Helical
Transmembrane Count
1
Entrez Gene Symbol
Gene Description
CD4 molecule
Chromosome
12
Position
6786858-6820799
Frequency
5
EVMP Score
0.50
Fluorescence & Localization
Cell SpecificRetinal amacrine cellsSingle-Nuclei Brain Specificcerebellar inhibitory
Function & Pathway
Protein Function
  • Predicted intracellular proteins
  • CD markers
  • Human disease related genes:Immune system diseases:Primary immunodeficiency
  • Transporters:Accessory Factors Involved in Transport
  • Disease related genes
  • FDA approved drug targets:Biotech drugs
Mediation Categories
Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediationImmune mediationReceptor-signaling mediation
Relations & Evidence

Enzyme-Mediated Modification

3 records.

Substrate Gene SymbolEnzyme Gene SymbolEnzyme UniProt IDResidue TypeResidue OffsetModificationDatabaseReferences
CD4PRKCAP17252S440phosphorylationPhosphoSite_MIMPMIMPProtMapperPhosphoSitePhosphoSite_ProtMapper
CD4PRKCAP17252S433phosphorylationphosphoELM_MIMPPhosphoSite_MIMPMIMPProtMapperPhosphoSitePhosphoSite_ProtMapper
CD4PRKCQQ04759S433phosphorylationREACH_ProtMapperProtMapperProtMapper:19050241

Ligand-Receptor Signaling

49 records.

CategoryParentDatabaseTransmitterReceiverSecretedPlasma Membrane (Transmembrane)Plasma Membrane (Peripheral)
plasma_membraneplasma_membraneOmniPathNoNoNoYesNo
plasma_membrane_transmembraneplasma_membrane_transmembraneMembranomeNoNoNoYesNo
plasma_membrane_transmembraneplasma_membrane_transmembraneCSPANoNoNoYesNo
plasma_membrane_transmembraneplasma_membrane_transmembraneOmniPathNoNoNoYesNo
cell_surfacecell_surfaceSurfaceomeNoNoNoYesNo
cell_surfacecell_surfaceconnectomeDB2020NoNoNoYesNo
cell_surfacecell_surfaceOmniPathNoNoNoYesNo
receptorreceptortalklrNoYesNoYesNo
receptorreceptorCellinkerNoYesNoYesNo
receptorreceptorscConnectNoYesNoYesNo
Page 4 of 5PreviousNext

Regulatory Interaction Network

64 records.

Source Protein SymbolSource UniProt IDTarget Protein SymbolTarget UniProt IDIs DirectedIs StimulationIs InhibitionDatabaseReferences
COMPLEX:CHEBI:166824_CHEBI:53000_P01909_P13762CD4P01730YesYesNoSIGNORSIGNOR:31001252
COMPLEX:CHEBI:166824_CHEBI:53000_P06340_P28068CD4P01730YesYesNoSIGNORSIGNOR:31001252
COMPLEX:CHEBI:166824_CHEBI:53000_P06340_P79483CD4P01730YesYesNoSIGNORSIGNOR:31001252
COMPLEX:CHEBI:166824_CHEBI:53000_P01906_Q30154CD4P01730YesYesNoSIGNORSIGNOR:31001252
COMPLEX:CHEBI:166824_CHEBI:53000_P20036_P28068CD4P01730YesYesNoSIGNORSIGNOR:31001252
COMPLEX:CHEBI:166824_CHEBI:53000_P13765_P20036CD4P01730YesYesNoSIGNORSIGNOR:31001252
COMPLEX:CHEBI:166824_CHEBI:53000_P01903_P01911CD4P01730YesYesNoSIGNORSIGNOR:31001252
COMPLEX:CHEBI:166824_CHEBI:53000_P01903_P01912CD4P01730YesYesNoSIGNORSIGNOR:31001252
COMPLEX:CHEBI:166824_CHEBI:53000_P04440_P20036CD4P01730YesYesNoSIGNORSIGNOR:31001252
COMPLEX:CHEBI:166824_CHEBI:53000_P01912_P28067CD4P01730YesYesNoSIGNORSIGNOR:31001252
Page 5 of 7PreviousNext

Protein Complex Composition

27 records.

Component NameComponent Gene SymbolsComponent UniProt IDStoichiometryDatabaseDatabase IDsReferences
CD44-ERK1-ERK2-RHAMM complexCD44HMMRMAPK1MAPK3O75330P16070P27361P284820:0:0:0CORUMCORUM:750417392272
Cd74-Cd44 receptor complexCD44CD74P04233P160701:1CellinkerCompleatCellChatDBCompleat:HC6218056708
Interleukin-16 receptor-ligand complexCD4IL16P01730Q140051:1ComplexPortalintact:EBI-5504135627231345942278096996301475529210809960
ABCD4DEPDC1FAM234BFRMD5LAPTM4ARUSF1TMEM214A2RU67O14678Q15012Q5TB30Q6NUQ4Q7Z6J6Q96GQ50:0:0:0:0:0:0hu.MAP2
ABCD4DEPDC1FAM234BFRMD5LAPTM4ARUSF1A2RU67O14678Q15012Q5TB30Q7Z6J6Q96GQ50:0:0:0:0:0hu.MAP2
ABCD4FAM234BFRMD5LAPTM4AA2RU67O14678Q15012Q7Z6J60:0:0:0hu.MAP2
ABCD4FAM234BFRMD5A2RU67O14678Q7Z6J60:0:0hu.MAP2
ABCD4O146782PDBPDB:6jbj
BLTP1BTRCGLI3PDCD4SLC16A4O15374P10071Q2LD37Q53EL6Q9Y2971:1:1:1:1NetworkBlastCompleatCompleat:HC4003
FAM114A2HSPA12APDCD4RAB5IFTMEM51O43301Q53EL6Q9BUV8Q9NRY5Q9NW970:0:0:0:0hu.MAP
Page 1 of 3Next

Isolation & Detection Technology

1 record.

EV Isolation MethodDetection MethodNumber of ReferencesReferences
Differential UltracentrifugationSize Exclusion ChromatographyWestern blotting130646616
Sequence, Structure & Domains

Sequences

Length
458
Mass
51,111
Sequence
MNRGVPFRHLLLVLQLALLPAATQGKKVVLGKKGDTVELTCTASQKKSIQFHWKNSNQIKILGNQGSFLTKGPSKLNDRADSRRSLWDQGNFPLIIKNLKIEDSDTYICEVEDQKEEVQLLVFGLTANSDTHLLQGQSLTLTLESPPGSSPSVQCRSPRGKNIQGGKTLSVSQLELQDSGTWTCTVLQNQKKVEFKIDIVVLAFQKASSIVYKKEGEQVEFSFPLAFTVEKLTGSGELWWQAERASSSKSWITFDLKNKEVSVKRVTQDPKLQMGKKLPLHLTLPQALPQYAGSGNLTLALEAKTGKLHQEVNLVVMRATQLQKNLTCEVWGPTSPKLMLSLKLENKEAKVSKREKAVWVLNPEAGMWQCLLSDSGQVLLESNIKVLPTWSTPVQPMALIVLGGVAGLLLFIGLGIFFCVRCRHRRRQAERMSQIKRLLSEKKTCQCPHRFQKTCSPI

3D Structural Models

Turn
75..79
Helix
84..89; 101..103; 176..178; 398..421; 432..438
Beta Strand
27..32; 37..39; 44..47; 51..55; 56..58; 60..63; 68..71; 94..96; 105..111; 114..128; 131..134; 135..137; 139..144; 152..156; 158..160; 162..172; 180..188; 191..199; 200..202; 426..428; 440..442
3D Structure
Electron microscopy (29); NMR spectroscopy (3); X-ray crystallography (50)

Domain & Motif Annotations

Domain (CC)
The Ig-like V-type domain mediates the interaction with MHCII.
Domain (FT)
26..125; Ig-like V-type; 126..203; Ig-like C2-type 1; 204..317; Ig-like C2-type 2; 318..374; Ig-like C2-type 3
Region
427..455; HIV-1 Vpu-susceptibility domain
Clinical Relevance
Disease Involvement
FDA approved drug targets
Biomarker
Phase 3; Phase 2; Approved; Phase 1; Discontinued in Phase 2; Investigative
Drug Targets
FDA approved drug targets
Interaction Protein
ENSG00000182866
Interaction Count
1
Interaction Dataset
intact_biogrid